56891-69-1

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 3-cyano-2-mercapto-6-methylisonicotinate is used as an intermediate in the synthesis of pharmaceuticals for its ability to act as a ligand in coordination chemistry. Its unique functional groups enable the development of new drugs with enhanced efficacy and reduced side effects.
Used in Agrochemical Industry:
In the agrochemical industry, Ethyl 3-cyano-2-mercapto-6-methylisonicotinate is utilized as an intermediate in the synthesis of agrochemicals. Its versatile structure allows for the creation of new compounds with improved performance in pest control and crop protection, while minimizing the environmental impact.
Used in Medicinal Chemistry Research:
Ethyl 3-cyano-2-mercapto-6-methylisonicotinate is used as a building block in medicinal chemistry research for the synthesis of various organic molecules. Its functional groups facilitate the development of novel compounds with potential therapeutic applications, contributing to the advancement of drug discovery and design.

InChI:InChI=1/C10H10N2O2S/c1-3-14-10(13)7-4-6(2)12-9(15)8(7)5-11/h4H,3H2,1-2H3,(H,12,15)/p-1

Upstream product

• 7357-70-2 Cyanothioacetamide 
• 615-79-2 ethyl 2,4-diketopentanoate 

Downstream Products

• 635730-86-8 3-amino-6-methylthieno[2,3-b]pyridine-2,4-dicarboxylic acid 2-amide 4-phenylamide 
• 635730-99-3 3-amino-4-(1hydroxy-2-phenylethyl)-6-methylthieno[2,3-b]pyridine-2-carboxylic acid amide 
• 635730-97-1 3-amino-4-(hydroxyphenylmethyl)-6-methylthieno[2,3-b]pyridine-2-carboxylic acid amide 
• 193617-23-1 3-Acetyl-2-hydroxy-7-methyl-4-(3-trifluoromethyl-phenyl)-thieno[2,3-b;4,5-b']dipyridine-9-carboxylic acid ethyl ester 
• 193617-22-0 3-Acetyl-2-hydroxy-7-methyl-4-(4-nitro-phenyl)-thieno[2,3-b;4,5-b']dipyridine-9-carboxylic acid ethyl ester 
• 193617-25-3 3-Acetyl-4-(2,4-dichloro-phenyl)-2-hydroxy-7-methyl-thieno[2,3-b;4,5-b']dipyridine-9-carboxylic acid ethyl ester 
• 193617-21-9 3-Acetyl-2-hydroxy-4-(4-methoxy-phenyl)-7-methyl-thieno[2,3-b;4,5-b']dipyridine-9-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

Methods for treating Hepatitis C

In accordance with the present invention, compounds that can inhibit viral replication, preferably Hepatitis C Virus (HCV) replication, have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the treatment or prevention of a viral infection are provided. In another aspect of the invention, compounds useful in the treatment or prevention of HCV infection are provided.

SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES

Disclosed are compounds of formula (I), wherein R1 and R2 are defined herein, which are useful as inhibitors of the kinase activity of the IκB kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.